Day K - Search Results

1

Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).

Ambrosini A, Estemalik E, Pascual J, Rettiganti M, Stroud C, Day K, Ford J. Ambrosini A, et al. Among authors: day k. J Manag Care Spec Pharm. 2022 Jun;28(6):645-656. doi: 10.18553/jmcp.2022.21375. Epub 2022 Apr 22. J Manag Care Spec Pharm. 2022. PMID: 35451858 Clinical Trial.

2

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Ament M, Day K, Stauffer VL, Skljarevski V, Rettiganti M, Pearlman E, Aurora SK. Ament M, et al. Among authors: day k. J Headache Pain. 2021 Feb 6;22(1):6. doi: 10.1186/s10194-021-01215-9. J Headache Pain. 2021. PMID: 33549036 Free PMC article. Clinical Trial.

3

Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis.

Stauffer VL, Oakes TM, Rettiganti M, Day KA, Camporeale A. Stauffer VL, et al. J Neurol. 2021 May;268(5):1980. doi: 10.1007/s00415-021-10416-w. Epub 2021 Feb 15. J Neurol. 2021. PMID: 33590341 No abstract available.

4

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Ament M, Day K, Stauffer VL, Skljarevski V, Rettiganti M, Pearlman E, Aurora SK. Ament M, et al. Among authors: day k. J Headache Pain. 2021 Aug 26;22(1):100. doi: 10.1186/s10194-021-01307-6. J Headache Pain. 2021. PMID: 34445967 Free PMC article. No abstract available.

5

100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies.

Rosen N, Pearlman E, Ruff D, Day K, Jim Nagy A. Rosen N, et al. Among authors: day k. Headache. 2018 Oct;58(9):1347-1357. doi: 10.1111/head.13427. Epub 2018 Oct 20. Headache. 2018. PMID: 30341990 Free PMC article. Clinical Trial.

6

Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.

Stauffer VL, Turner I, Kemmer P, Kielbasa W, Day K, Port M, Quinlan T, Camporeale A. Stauffer VL, et al. Among authors: day k. J Headache Pain. 2020 Jun 23;21(1):79. doi: 10.1186/s10194-020-01148-9. J Headache Pain. 2020. PMID: 32576229 Free PMC article. Clinical Trial.

7

Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine.

Stauffer VL, Wang S, Bonner J, Kim B, Bhandari R, Day KA, Camporeale A. Stauffer VL, et al. BMC Neurol. 2020 May 19;20(1):194. doi: 10.1186/s12883-020-01775-4. BMC Neurol. 2020. PMID: 32429851 Free PMC article. Clinical Trial.

8

Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine.

Rosen N, Pearlman E, Ruff D, Day K, Nagy AJ. Rosen N, et al. Among authors: day k. Headache. 2019 Apr;59(4):627-628. doi: 10.1111/head.13514. Headache. 2019. PMID: 30973202 Free PMC article. No abstract available.

9

Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine.

Igarashi H, Shibata M, Ozeki A, Day KA, Matsumura T. Igarashi H, et al. J Pain Res. 2021 Nov 16;14:3555-3564. doi: 10.2147/JPR.S326905. eCollection 2021. J Pain Res. 2021. PMID: 34815708 Free PMC article.

10

Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder.

Walker DJ, Mason O, Clemow DB, Day KA. Walker DJ, et al. Postgrad Med. 2015;127(7):686-701. doi: 10.1080/00325481.2015.1081046. Postgrad Med. 2015. PMID: 26343377 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters